Intervention Protocol

Statins for influenza and pneumonia

  1. Gulam Khandaker1,*,
  2. Harunor Rashid2,
  3. Maria YK Chow1,
  4. Robert Booy1

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 19 JAN 2011

DOI: 10.1002/14651858.CD008916


How to Cite

Khandaker G, Rashid H, Chow MYK, Booy R. Statins for influenza and pneumonia (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008916. DOI: 10.1002/14651858.CD008916.

Author Information

  1. 1

    The Children's Hospital at Westmead, National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia

  2. 2

    Barts and the London School of Medicine and Dentistry, Centre for Paediatrics, London, UK

*Gulam Khandaker, National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales, 2145, Australia. gulamk@chw.edu.au. tuhinmmc@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 19 JAN 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to assess the efficacy and safety of statins in people with influenza and pneumonia. Comparisons will be made between people who have received statin therapy with those who have not received any statin therapy. This review will explore the following questions.

  1. Do statins reduce mortality from influenza and pneumonia?
  2. Do statins reduce morbidity and severity of influenza and pneumonia?
  3. How safe is it to administer statins to people with influenza and pneumonia?